Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1613
Full metadata record
DC FieldValueLanguage
dc.contributor.authorREGNO.BJ0120002-
dc.date.accessioned2024-05-06T07:18:49Z-
dc.date.available2024-05-06T07:18:49Z-
dc.date.issued2023-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1613-
dc.description.abstractBackground: Postpartum hemorrhage (PPH) is a leading cause of maternal morbidity and mortality. Efforts to reduce blood loss during and after delivery are imperative. Tranexamic acid is an anti-fibrinolytic agent that reduces blood loss. This study is conducted to shed light on its role in women with high-risk factors for PPH undergoing cesarean sections. Objective: To assess the role of tranexamic acid in reducing blood loss during elective and emergency cesarean deliveries in women at high risk for postpartum hemorrhage.en_US
dc.language.isoen_USen_US
dc.publisherKLE Academy of Higher Education and Research, Belagavien_US
dc.subjectPostpartum hemorrhage, Tranexamic acid, Cesarean section, Randomized controlled trial.en_US
dc.titleTo assess the role of tranexamic acid in Reducing the blood loss in women at high Risk for postpartum hemorrhage Undergoing cesarean section – a Randomized controlled trialen_US
dc.typeDissertationsen_US
Appears in Collections:Obstetrics & Gynaecology MS

Files in This Item:
File Description SizeFormat 
BJ0120002.pdf2.09 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.